Expression of mir-33a/b in hepatoma cells treated with atorvastatin (2012)
Zambrano Velasco, José Alberto; Cerda, Alvaro; Hirata, Mario Hiroyuki 
; Hirata, Rosario Dominguez Crespo ; Salazar, Luís
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: CÉLULAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBRANO VELASCO, José Alberto et al. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 09 nov. 2024. , 2012APA
Zambrano Velasco, J. A., Cerda, A., Hirata, M. H., Hirata, R. D. C., & Salazar, L. (2012). Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Zambrano Velasco JA, Cerda A, Hirata MH, Hirata RDC, Salazar L. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 45 res. FCF085.[citado 2024 nov. 09 ]Vancouver
Zambrano Velasco JA, Cerda A, Hirata MH, Hirata RDC, Salazar L. Expression of mir-33a/b in hepatoma cells treated with atorvastatin. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 45 res. FCF085.[citado 2024 nov. 09 ]
